Drug intelligence / Profile preview

FPE024

Development stage: Unknown
Lead developer: Guangdong Fapon Biopharma
Modality: Trispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, T-cell Engagers → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics

Overview

FPE024 is a trispecific antibody drug candidate developed by Guangdong Fapon Biopharma. It functions as a bispecific T-cell engager (BiTE) targeting B-cell maturation antigen (BCMA), CD19, and CD3. The drug acts as an inhibitor of BCMA and CD19 while stimulating CD3, aiming to redirect T cells to eliminate pathogenic B cells implicated in autoimmune diseases such as systemic lupus erythematosus. Its primary therapeutic focus is on immune system diseases, with additional exploration in skin and musculoskeletal disorders. As of the latest update, its highest development phase is discovery[1][2].

Targets

BCMA (B-cell maturation antigen)CD3 (T-cell surface glycoprotein CD3)CD19 (B lymphocyte antigen CD19)

Beyond the preview

Go deeper on FPE024.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FPE024.

Explore the full profile